Yahoo
    NasdaqGS - Nasdaq Real Time Price USD

    Crinetics Pharmaceuticals, Inc. (CRNX)

    84.95 0.00 (0.00%)
    At close: August 31 at 4:00:00 PM EDT
    Trade CRNX on Coinbase
    Loading Chart for CRNX
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform

    Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform
    InvestorsHub 3d ago
    Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?

    Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?
    Zacks 4d ago
    Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal

    Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal
    Insider Monkey 1mo ago
    Why This Pharmaceutical Stock Jumped Close to 100% This Week

    Why This Pharmaceutical Stock Jumped Close to 100% This Week
    Motley Fool 1mo ago
    Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

    Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults
    GlobeNewswire 4mo ago
    Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?

    Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?
    Insider Monkey 1mo ago
    Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

    Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
    GlobeNewswire 2mo ago
    Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

    Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates
    Zacks 3mo ago
    Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

    Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
    GlobeNewswire 4mo ago
    Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations

    Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations
    GlobeNewswire 3mo ago
    Crinetics soars on $10B acquisition by Vertex

    Crinetics soars on $10B acquisition by Vertex
    Investing.com 1mo ago

    Related Tickers

    CYTK
    PTGX
    IDYA
    MLYS
    NUVL
    SRRK
    TVTX
    REPL
    ASND
    APGE
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: